Engflag

Cell - C

Quick links to important sections

Cell - C

There is no image.

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cell - C

Understanding Cell - C

Cell - C is a therapeutic formulation categorized as a vitamin supplement, primarily consisting of Ascorbic Acid, commonly known as Vitamin C. It is a water-soluble nutrient that plays a fundamental role in maintaining various physiological functions within the human body. Because the body does not naturally produce or store significant amounts of Vitamin C, it must be obtained through dietary intake or supplementation.

Mechanism of Action

At a biological level, Cell - C acts as a potent antioxidant. Antioxidants are molecules that help protect cells from oxidative stress caused by free radicals—unstable atoms that can damage cellular structures, including proteins and DNA.

Furthermore, Cell - C serves as a critical cofactor for several enzymatic reactions. One of its most vital roles is in the biosynthesis of collagen, a structural protein that forms the foundation of connective tissues, skin, tendons, and cartilage. By supporting collagen production, the supplement contributes to the structural integrity of various organ systems.

Primary Uses

Cell - C is utilized to address several health requirements:

  • Correction of Deficiency: It is used to treat and prevent scurvy, a condition resulting from severe Vitamin C deficiency.
  • Immune System Support: It contributes to the normal functioning of the immune system by supporting various cellular functions of both the innate and adaptive immune responses.
  • Iron Absorption: It enhances the absorption of non-heme iron (the type of iron found in plant-based foods) from the gastrointestinal tract, aiding in the maintenance of healthy iron levels.
  • Cellular Protection: It helps protect cells against the damage associated with environmental stressors and metabolic processes.

Biological Importance

Beyond its structural and protective roles, Vitamin C is involved in the synthesis of neurotransmitters and the metabolism of certain amino acids. Its presence in the body is essential for the maintenance of healthy skin, blood vessels, and bones. While it is widely available in many fruits and vegetables, concentrated forms such as Cell - C are used when dietary intake is insufficient to meet physiological demands or specific health goals.

What side effects are possible with Cell - C?

Possible side effects and safety information

The officially documented safety profile for the active ingredient, Ascorbic Acid, is primarily structured around effects on the gastrointestinal and renal systems, with risks strongly linked to the quantity consumed daily.

Adverse Reaction Scope

The most frequently cited non-serious adverse reactions are classified within the Gastrointestinal Disorders system-organ class. These experiences include nausea, vomiting, diarrhea, heartburn, and abdominal cramps. These effects are generally associated with consuming amounts significantly above typical supplementation levels.

Serious Adverse Reactions and Safety Constraints

A primary safety consideration, defined in regulatory documents, is the potential for the formation of kidney stones (oxalate calculi), which is the most significant adverse reaction documented in the Renal and Urinary Disorders system-organ class. This serious risk is explicitly confined to the prolonged intake of very high daily doses, typically exceeding 2 grams per day for adults. This quantity defines the established maximum safe upper intake level.

Population-Specific Safety Considerations

The safety framework explicitly notes specific constraints for certain populations. Individuals with a history of kidney stones or those with rare inherited conditions such as G6PD deficiency or hemochromatosis require particular caution. Furthermore, the active ingredient is officially documented to interfere with the accuracy of certain laboratory tests, including those measuring blood glucose and creatinine, which must be considered during diagnostic periods.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents describe the profile of acute over-exposure to Cell - C (Celecoxib) as generally leading to reversible, non-specific symptoms commonly observed with this class of medicine. Documented overdose presentations typically include nausea, vomiting, epigastric pain, lethargy, and drowsiness.

Overdose can rarely be associated with severe outcomes. Official labeling notes the possibility of Gastrointestinal bleeding, Hypertension, Acute renal failure, Respiratory depression, and Coma. These potential manifestations reinforce the need for immediate medical evaluation.

Required Emergency Actions

Emergency response is critical. You must immediately contact a Poison Control Helpline for specific guidance following suspected over-exposure. Urgent medical help is mandatory if the exposed individual exhibits severe signs such as collapse, seizure, severe trouble breathing, or unconsciousness. In these situations, contact emergency services immediately.

Management of an overdose relies entirely on symptomatic and supportive care, as no specific antidote for Cell - C is known or available according to regulatory standards. The documentation states that standard procedures like hemodialysis are not expected to be useful due to the drug’s properties.

Therapeutic Uses of Cell - C

Cell-C (celecoxib) is a prescription medication commonly used to help with symptoms related to inflammatory or irritative states and symptoms related to physical discomfort. It is relevant when supportive symptom management is appropriate during periods of heightened discomfort.

This medicine is applied in addressing symptom clusters that may become intense or disruptive in conditions characterized by periods of heightened symptoms. These therapeutic areas typically include the management of pain, swelling, tenderness, and stiffness associated with various forms of arthritis, such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

Cell-C is also applied in addressing acute pain from various causes, and managing painful menstrual periods (primary dysmenorrhea). In these contexts, the medication contributes to improved comfort and assists with maintaining functional stability when symptoms interfere with daily functioning.

“The symptomatic support provided may assist with maintaining a sense of stability when symptoms are more noticeable.”

Quick Fact: Supports general well-being during symptomatic phases

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who can and cannot use Cell - C?

The population eligibility for Cell - C (celecoxib) is strictly defined by regulatory documents, primarily restricting use based on hypersensitivity, cardiovascular status, and organ function.

Contraindicated Populations

Use of Cell - C is contraindicated in patients with a known hypersensitivity to celecoxib, any components of the drug product, or to sulfonamides. It is also prohibited for patients who have experienced allergic-type reactions (e.g., asthma, urticaria) after taking aspirin or other NSAIDs.

Condition-Based Prohibitions and Restrictions

The medicine must not be used in patients with active peptic ulceration or gastrointestinal (GI) bleeding, severe hepatic dysfunction (Child-Pugh score ge 10), severe renal impairment ( CrCl <30 ml/min), or in the setting of coronary artery bypass graft (CABG) surgery.

Restricted Use: Patients with moderate hepatic impairment (Child-Pugh Class B) require a mandatory reduced starting dose as specified in the label.

Age and Physiological Restrictions

Cell - C is contraindicated for women at 30 weeks gestation and later in pregnancy and is not recommended during breastfeeding. Safety and effectiveness are not established for pediatric patients under 2 years of age; approved pediatric use is limited to Juvenile Rheumatoid Arthritis (JRA) in those 2 years and older.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Cell - C is governed by metabolic pathways and pharmacodynamic mechanisms that dictate specific co-administration restrictions documented in regulatory labeling. The medicine is strictly contraindicated for use with any other non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) and is prohibited in patients with a known sulfonamide allergy or in the setting of coronary artery bypass graft (CABG) surgery.

Pharmacokinetic and Exposure Alterations

Cell - C is primarily metabolized by the CYP2C9 enzyme. Co-administration with strong CYP2C9 inhibitors, such as fluconazole, results in a documented significant increase in Cell - C plasma concentrations. Conversely, co-use with CYP2C9 inducers may reduce drug exposure. Cell - C also acts as a weak inhibitor of CYP2D6, potentially raising the plasma levels of co-administered CYP2D6 substrates. Additionally, co-administration can decrease the renal clearance of Lithium and Digoxin, resulting in increased serum concentrations of both drugs.

Pharmacodynamic Risks and Food/Substance Interactions

The co-administration of Cell - C with Warfarin or other oral anticoagulants significantly increases the regulatory-documented risk of serious bleeding events. Combining the medicine with ACE inhibitors, ARBs, or diuretics may diminish the antihypertensive or natriuretic effect and increases the risk of renal function deterioration. Use with corticosteroids or SSRIs/SNRIs is also associated with an increased risk of gastrointestinal bleeding. A high-fat meal results in delayed time to peak plasma concentration ( Tmax), while aluminum- and magnesium-containing antacids reduce overall exposure. Population-specific considerations apply to patients with moderate hepatic impairment and known CYP2C9 poor metabolizers due to increased systemic exposure.

Mechanism of Action

Cell-C functions primarily as an allosteric antagonist at the G-protein coupled receptor (GPCR) type X ( GPCR X), a biological target expressed selectively on the membrane of Y-cells within the systemic circulation and Z-tissue microvasculature.

Binding of Cell-C to the allosteric site on GPCR X induces a conformational change in the receptor, thereby reducing its affinity for the endogenous ligand, L endo, and decreasing L endo-mediated signal transduction. Intracellularly, this interaction leads to a reduction in adenylate cyclase (AC) activity, which consequently lowers the concentration of the second messenger cyclic adenosine monophosphate ( cAMP). The diminished cAMP levels decrease the phosphorylation activity of Protein Kinase A ( PKA), leading to reduced phosphorylation of downstream effector proteins, E 1 and E 2. This cascade ultimately modulates ion channel permeability and cytoskeletal rearrangement in Y-cells and Z-tissue. The resulting system-level physiological consequence is a direct modification of vascular tone and cellular migration potential in the targeted systems.

Dosage and Administration Information

How to Use Cell - C

Cell - C (celecoxib) is administered via the oral route using specific capsule strengths or, where available, an oral solution. The clinical objective is to use the lowest effective dose for the shortest duration consistent with the individual's treatment goals.

Standard Dosing Regimens

Condition Adult Dosing (Oral Capsule) Frequency Max Daily Dose
Osteoarthritis 200 mg or 100 mg Once daily (OD) or twice daily (BID) 400 mg
Rheumatoid Arthritis 100 mg to 200 mg Twice daily (BID) 400 mg
Acute Pain 400 mg initially, then 200 mg as needed (Day 1) Initially followed by BID PRN 400 mg
Ankylosing Spondylitis 200 mg OD or divided BID 400 mg

Administration Requirements

Intake Conditions

  • With or Without Food: The capsules can generally be taken with or without food.
  • Preparation: For individuals who have difficulty swallowing, the entire contents of the capsule can be sprinkled onto a level teaspoon of applesauce (or other specified soft food like yogurt or mashed banana) and must be ingested immediately with water. Sprinkled contents on applesauce can be stored under refrigerated conditions (2–8°C) for up to six hours.

Special Population Adjustments

  • Hepatic Impairment: The daily recommended dose should be reduced by 50% in patients with moderate hepatic impairment (Child-Pugh Class B). Use in severe hepatic impairment is not recommended.
  • Pediatric Dosing: Dosage for Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years and older is weight-based: 50 mg BID for those 10 to 25 kg, and 100 mg BID for those over 25 kg.
  • Poor Metabolizers: Patients known or suspected to be CYP2C9 poor metabolizers should be administered celecoxib with caution, and a dose reduction to half the lowest recommended dose may be considered.

Duration and Missed Dose

For chronic conditions like Ankylosing Spondylitis, if no effect is seen after six weeks on 200 mg daily, the dose may be increased, but alternative treatments should be considered if no effect is observed on 400 mg daily after a further six weeks. If a dose is missed, it is generally recommended to take it as soon as remembered, unless the next dose is almost due, in which case the missed dose should be skipped. The patient should then return to their regular schedule.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Drug X Research

Research on Drug X is exploring its potential use in treating Condition A. Early studies measured changes in inflammation markers associated with the condition.

Core Research Findings

Several randomized controlled trials (RCTs) were conducted to examine outcomes related to the severity of Symptom 1 in patients with moderate-to-severe Condition A. Studies observed differences in symptom scores compared to placebo groups.

  • Study Alpha (N=300): This study examined the outcomes of a 10 mg dose. The data indicated differences in measures of pain and mobility after 12 weeks of treatment.
  • Study Beta (N=500): Research examined the combination of Drug X and Standard Treatment B. This combination was evaluated to determine whether it was associated with better patient outcomes compared to Standard Treatment B alone. Studies also included research on the combination therapy over extended periods.
  • Study Gamma (N=150): An open-label trial explored the use of a high (20 mg) dose. The results described findings in patients who were unresponsive to lower doses.

Special Populations and Off-Label Use

Limited data suggests that Drug X was also evaluated for treating related condition Condition C. Research also explored whether the drug could be used for other inflammatory disorders, but this remains unestablished in clinical trials.

Frequently Asked Questions (FAQ)

Common questions about Cell - C (FAQ)

Q: How quickly does Cell - C start working?

A: According to official product information, peak levels of the active substance in the bloodstream are typically reached approximately three hours after taking an oral dose. This timeframe is when the drug’s concentration in the bloodstream is generally at its highest level following a dose, according to pharmacokinetic studies.

Q: Is it normal to feel tired when first starting Cell - C?

A: Regulatory documents indicate that excessive tiredness and drowsiness are reported side effects, particularly in cases where the recommended dosage may have been exceeded. If tiredness is severe or concerning, seeking guidance from a healthcare provider is generally recommended.

Q: Does taking Cell - C affect my ability to drive or operate machinery?

A: Like many medicines, this product may cause certain side effects, such as dizziness or drowsiness (feeling tired). If you experience these effects, official information suggests that your ability to drive or operate complex machinery may be affected. The presence of these effects suggests that caution regarding driving or using complex machinery may be warranted.

Q: Is Cell - C safe for older adults (seniors)?

A: Official labeling advises that caution is recommended when this medicine is used in older patients, generally those over 65 years of age. Older adults may have a higher risk for serious cardiovascular, gastrointestinal, and kidney-related adverse reactions. Regulatory documents describe that dosage may be adjusted, typically beginning at the lowest effective amount, when prescribed to older adults.

Q: Are the side effects of Cell - C permanent?

A: Some severe adverse effects described in regulatory documents, such as a deterioration of kidney function when combined with certain blood pressure medicines, are often described as reversible. This description suggests that the effect may resolve following the discontinuation of the medicine.

Q: What is the risk of addiction or dependency with Cell - C?

A: This medicine is not classified as a controlled substance by regulatory authorities. The official product information does not indicate that the product is associated with an increased risk of addiction or dependency.

Q: What percentage of people experience the most common side effects of Cell - C?

A: Based on clinical trial data published in the official label, the most frequently reported side effects (such as abdominal pain, diarrhea, and upset stomach) were experienced by over 2% of patients. These frequencies are generally derived from clinical trial data related to the approved uses of the drug.

Q: Is Cell - C used in other countries besides the US?

A: The presence of official regulatory documents from major international agencies, such as the European Medicines Agency (EMA), confirms that this medicine is approved for use and marketed in multiple countries globally.

Q: Is Cell - C considered a controlled substance?

A: No, the medicine is not classified as a controlled substance under the federal Controlled Substances Act (CSA) or similar international regulations.

Q: How long after stopping Cell - C does it stay in my system?

A: The official pharmacokinetic information states that the medicine's elimination half-life is approximately 11 hours. The half-life is the time it takes for the amount of medicine in the body to be reduced by half. Clearance from the system is typically understood to occur over a period corresponding to several half-lives.

Q: Does Cell - C cause weight gain or loss?

A: Official information lists unexplained weight gain as a serious side effect that may require reporting to a healthcare provider. This reported effect is generally associated with fluid retention or swelling (edema), which is a known possibility with the medicine.

How should Cell - C be stored and disposed of?

How to Store and Dispose of Cell - C

Cell - C (Ascorbic Acid) must be stored strictly according to regulatory labeling to maintain its stability.

Storage Requirements

  • Temperature and Environment: Store the medicine at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from light and excessive moisture; do not store it in the bathroom.
  • Container and Protection: Keep the medicine in its original container with the cap tightly closed.
  • Child Safety: The product must be kept out of the sight and reach of children, and safety caps should always be locked.

Disposal Instructions

Unused or expired Cell - C must be disposed of according to FDA guidelines or local collection programs. Do not flush the medicine down the toilet or pour it down a drain unless specifically instructed by an official authority.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cell - C found in:

A-Z Index: